The Medicare Payment Advisory Commission (MedPAC) convened a session on structural differences between the Part D standalone prescription drug plan (PDP) and the Medicare Advantage prescription drug plan (MA-PD) markets. In the presentation, Senior Analyst Tara Hayes and Principal Policy Analysts Shinobu Suzuki and Andy Johnson detailed how enrollment has shifted to MA-PDs and the stability of the PDP market… (Slifer, November 7, 2024) #Medicare Advantage, #Medicare Part D